Smart Pumps in Practice: Survey Results Reveal Widespread Use, but Optimization Is Challenging
In two recent surveys on smart infusion pump (smart pump) usage in the US, more than 1,000 nurses, pharmacists, and other healthcare professionals provided ISMP with a unique glimpse into the successes, safety concerns, and barriers with the optimization of smart pumps. Most respondents reported widespread use of smart pumps and demonstrated a commitment to employing reliable drug libraries capable of reducing administration errors with parenteral infusions, including pump programming errors. However, respondents were also very candid about their many frustrations and challenges with maximizing this technology, which included significant limitations in pump capabilities, alarm fatigue, and persistent deficiencies related to library use and updates, availability of the pumps, programming workflow, secondary infusions, and pump data analysis.
About Smart Pumps
Smart pumps with dose-error reduction software (DERS) allow organizations to create a tailored library of medications with dosing guidelines by establishing standard concentrations, dosing limits, and alerts (e.g., clinical advisories, soft stops, hard stops). Smart pumps with enabled DERS can detect dosing and programming errors that may harm patients. They can also provide a great deal of data that is useful in improving safe practices, including compliance with using the drug library, alert types and frequency, action taken in response to an alert (e.g., reprogramming), and the frequency of overridden soft stops. The data can also help investigate pump-related errors and identify good catches as well as risky practices such as unnecessary nurse dilution of intravenous (IV) medications.
Between November 2017 and January 2018, ISMP conducted an 18-item smart pump survey for healthcare practitioners, a copy of which appeared in the November 16, 2017 ISMP Medication Safety Alert! A total of 618 respondents completed this survey, including nurses (68%) and advanced practice nurses (3%), pharmacists (22%), medication or patient safety officers (3%), and others (4%). Most (65%) were staff-level practitioners working in hospitals (95%) evenly distributed by bed size. Nearly half (42%) of the respondents reported current experience with managing smart pump drug libraries.
Between January and March 2018, ISMP also conducted a 7-item smart pump survey for frontline nurses only, a copy of which appeared in the January 2018 Nurse AdviseERR. Most of the items in this survey mirrored some of the key items in the 18-item survey, although the focus was on nursing use of the drug library when programming infusions. A total of 438 nurses completed this survey. Almost all respondents (95%) work in hospitals, in adult medical-surgical units (30%), adult critical care units (26%), the emergency department (ED) (13%), pediatric/neonatal units (7%), labor/delivery/perioperative areas (6%), or inpatient oncology units (5%).
The following is an analysis of the results from hospital respondents to either the 18-item survey (n=592), the 7-item survey (n=416), or both surveys (n=1,008).
Scope of use (18-item survey). More than 70% of respondents from larger hospitals with 100 beds or more and nearly half (45%) of respondents from smaller hospitals with less than 100 beds reported using smart pumps for more than 5 years. Another 22% of larger hospitals and 43% of smaller hospitals have been using smart pumps for 1-5 years. Overall, only 4% of respondents reported using smart pumps for less than 1 year, and fewer than 1% reported not using smart pumps at all in their facilities.
High usage of smart pumps was reported when administering IV medications (99%), IV fluids (96%), and blood (93%), with few differences between respondents from different size hospitals. Eighty-three percent of respondents also reported using smart pumps for parenteral nutrition (PN) and patient-controlled analgesia (PCA), although usage was lower in hospitals with less than 100 beds (PN=69%, PCA=74%). Smart pump usage varied among hospitals with less than 100 beds, 100-499 beds, and 500 and more beds for epidural infusions (36%, 57%, 62%, respectively) and syringe infusions (47%, 63%, 80%, respectively). Smart pump usage was lowest with magnetic resonance imaging (MRI) infusions, ranging from 8% in hospitals with less than 100 beds to 29% in hospitals with 500 and more beds. About 3% of respondents reported using smart pumps for other types of infusions, such as nerve blocks, continuous inhalation, and enteral feedings.
At least 97% of respondents reported consistently using smart pumps in medical-surgical units, pediatric units, adult and pediatric critical care units, neonatal intensive care units (NICUs), inpatient oncology units, post-anesthesia care units (PACUs), labor and delivery units, ambulatory infusion units, and EDs. Fewer respondents reported using smart pumps consistently in surgical suites (90%), endoscopy suites (87%), and radiology departments (84%). However, wide variability within these three patient care areas was reported among respondents from different size hospitals. For example, the use of smart pumps in endoscopy suites was reported by only 70% of respondents from hospitals with fewer than 100 beds, compared to 91% of respondents from larger hospitals.
Almost one-third (31%) of respondents who care for neonates and pediatric patients reported using the same smart pumps to administer parenteral infusions and enteral feedings. Most respondents (82%) who reported using different infusion pumps for these purposes also reported the availability of dedicated small volume enteral pumps.
Interoperability (18-item survey). Fifteen percent of respondents have implemented bi-directional interoperability between their smart pumps and electronic health record (EHR) that facilitates pump programming and documentation of the infusion in the EHR. Another 13% of respondents are planning implementation within the next 12 months. Most respondents who reported pump/EHR interoperability said it was available hospital-wide; few respondents reported that pumps were not interoperable in some areas of the hospital, such as the operating room, PACU, oncology unit, cardiac catheterization lab, ED, and/or NICU.
Wireless connectivity (18-item survey). One-quarter (25%) of respondents from hospitals with fewer than 100 beds do not have the infrastructure to wirelessly transfer data to and from smart pumps, while only 10% of respondents from larger hospitals reported no wireless connectivity. Most respondents with wireless connectivity use it to update drug libraries (97%) and obtain reports and data (70%). Pharmacists and manager/director/administrator-level respondents (82%) reported higher use of wireless connectivity to obtain reports than nurses and staff-level respondents (57%). One-third (33%) of respondents use wireless connectivity to track a pump’s location within the hospital.
Drug library profiles and updates (18-item survey). Selection of the appropriate drug library when programming a pump is typically based on the patient care area (89%), although about half (47%) of respondents reported that the patient’s weight may be used, and approximately one-third (35%) said the library is selected according to the therapeutic drug class. About 6% of respondents noted that the library is differentiated according to patient age groups—adult, pediatric, or neonate. Half (50%) of respondents who manage the pump library reported 1 to 3 library modifications and updates during the past year; another 28% reported 4 to 6 annual updates. Only 17% said that the libraries had been updated more than 6 times in the past year, and fewer than 5% reported no updates.
Engaging the drug library (both surveys). In the 7-item survey, more than three quarters (79%) of frontline nurses who use smart pumps said they use the drug library for IV medications more than 90% of the time. In the 18-item survey, only half (48%) of all respondents reported compliance with the drug library greater than 90% of the time. However, the compliance rates may differ because, in the 18-item survey, all infusions in the drug library, including plain IV solutions and drugs by other routes of administration were included, while in the 7-item survey, nurses were asked to report compliance with using the library with IV medications separately from their compliance with using the library to program plain IV fluids. When asked the reasons for compliance rates lower than 90%, most nurses reported that medications or concentrations were not in the drug library (46% of nurses working in adult care units; 86% of nurses working in pediatric or neonatal units), or that the basic infusion mode was used in an emergency situation (33% of nurses working in the ED; 12% of nurses working in all other areas).
Only 3-5% of respondents in either survey reported using the drug library less than 50% of the time for IV medications. However, up to 45% of nurses who responded to these surveys reported that plain IV solutions are programmed outside the library as a basic infusion more than 50% of the time. In the 7-item survey, reasons for low compliance with using the drug library when infusing plain IV solutions included unavailability of the solution in the library (45%), a perception that it took too much time to program the plain solution through the library (19%), and nurses were not expected by the hospital to use the drug library for plain IV solutions (10%). The reasons for noncompliance did not vary much between different care locations.
Data analytics (both surveys). Nurses who completed the 7-item survey and healthcare practitioners who completed the 18-item survey were consistent in reporting how often they receive smart pump compliance data. Approximately two-thirds of all respondents who review compliance data said they receive the data either monthly (33%) or quarterly (35%). Approximately 11% of respondents receive compliance data daily or weekly, and about 10% receive it yearly. The remaining respondents receive compliance data every 6 months or less often than yearly. In both surveys, more than half of the respondents reported that compliance data was not available, or they were unaware of how often the data was reviewed. Staff-level practitioners (58%) were unaware of smart pump compliance rates than manager/director/administrator-level practitioners (19%).
Errors (both surveys). More than half of all respondents were aware of at least one error that happened during the prior 12 months despite the use of smart pumps (Table 1). The most common types of errors reported involved secondary infusions, including delayed or omitted secondary infusions caused by a closed roller clamp, or secondary infusions that were administered at the wrong rate. Other types of errors reported included programming errors due to dose-rate confusion, decimal point errors, weight-related errors, and selecting the wrong drug or dosing method in the drug library; IV line or channel mix-ups and tubing misconnections; hanging the wrong drug or solution; and administration of an infusion to the wrong patient.
|Error Type||% of Respondents Experiencing Errors|
|18-Item Survey||7-Item Survey|
|All (n=592)||Pharmacists (n=128)||Nurses (n=400)||Nurses (n=416)|
|Secondary infusions delayed/omitted due to roller clamp being closed||62||52||65||
|Wrong rate errors for secondary infusions||36||52||24||13|
|Dose-rate confusion during pump programming||46||57||39||19|
|IV line or channel mix-ups||32||33||26||12|
|Omission of decimal point (e.g., 1.2 entered as 12)||21||37||8||5|
|Selection of a zero instead of a decimal point (e.g., 1.2 entered as 102)||13||21||5||1|
|Wrong drug selected or hung||Not asked during survey, but 3% of respondents included examples related to these errors in the “other” category||12|
|Administered to the wrong patient||3|
|Infusion attached to the wrong access site (e.g., IV infusion attached to epidural site)||4|
|I am not aware of any errors in the past 12 months||Not asked during survey, but 80% of respondents selected at least one type of error||41|
|Other (most frequent examples included weight-related errors, selecting the wrong dosing method, pump failures)||20||14||22||8|
Biggest challenges (both surveys). Most respondents provided detailed accounts of the significant challenges they face when using smart pumps (Table 2)—more than 700 comments were provided! These challenges clearly fell into familiar categories of known vulnerabilities with smart pumps, the most frequent of which was related to the creation, maintenance, and use of the drug library. Common challenges detailed in this category included difficulty in securing agreement with prescribers regarding the drugs, standard concentrations, and dosing methods, and practitioners who routinely bypass the drug library. The difficulty with keeping the drug library up-to-date during the current drug shortage crisis was also frequently noted. Smart pump technology limitations were another category of challenges often cited by nurse respondents, who provided a myriad of improvements they would love to see in smart pumps, from less lag time when updating pump libraries to reducing the complexity of selecting the correct library when patients are transferred to a different care area. Some of the specified technology limitations were reinforced when describing the challenging workflow associated with programming the pump, including difficulty in finding the correct drug when scrolling through a large list of generic names, and the time-consuming and complex programming process. Challenges that often led to incorrect pump programming or problems with secondary infusions were detailed, particularly challenges associated with flushes and forgetting to restart the primary infusion when the secondary infusion has been administered. Overly sensitive and false alarms, lack of pump availability during times of high census, and problems associated with wireless connectivity and interoperability were also mentioned by dozens of respondents.
|Drug library creation, maintenance, and engagement||29||
|Alarms and sensors||10||
Next month, ISMP will be convening a national, invitational summit on smart pumps to update our current guidelines and establish new best practices. We sincerely thank the more than 1,000 healthcare practitioners who completed our surveys. Your thoughtful responses provide a glimpse into the current challenges and barriers to optimizing smart pump use. Overall, the findings from these surveys have helped shape the questions that need to be addressed during the summit. We are confident that your input will be a crucial factor in the summit’s success.